CytoDyn Inc.
CYDY
$0.25
-$0.01-2.00%
OTC PK
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.46% | 22.50% | |||
| Depreciation & Amortization | -- | -380.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.39% | 26.56% | |||
| Operating Income | 2.39% | -26.56% | |||
| Income Before Tax | 6.98% | -25.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.98% | -25.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.98% | -25.18% | |||
| EBIT | 2.39% | -26.56% | |||
| EBITDA | 2.39% | -26.61% | |||
| EPS Basic | 7.84% | -21.43% | |||
| Normalized Basic EPS | 6.67% | -15.38% | |||
| EPS Diluted | 38.96% | -83.33% | |||
| Normalized Diluted EPS | 6.67% | -15.38% | |||
| Average Basic Shares Outstanding | 1.07% | 0.90% | |||
| Average Diluted Shares Outstanding | 1.07% | 0.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||